Cargando…

Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy

This study used a streptozotocin (STZ)-induced rat model of diabetes to investigate whether Ras-related C3 botulinum toxin substrate 1 (Rac1) was involved in the pathogenesis of diabetic retinopathy. The effects of Rac1 inhibition on vascular endothelial (VE)-cadherin and β-catenin expression in hig...

Descripción completa

Detalles Bibliográficos
Autores principales: LI, YANG-JUN, ZHANG, JIE, HAN, JING, DU, ZHAO-JIANG, WANG, PING, GUO, YONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247314/
https://www.ncbi.nlm.nih.gov/pubmed/25452781
http://dx.doi.org/10.3892/etm.2014.2081
_version_ 1782346624187498496
author LI, YANG-JUN
ZHANG, JIE
HAN, JING
DU, ZHAO-JIANG
WANG, PING
GUO, YONG
author_facet LI, YANG-JUN
ZHANG, JIE
HAN, JING
DU, ZHAO-JIANG
WANG, PING
GUO, YONG
author_sort LI, YANG-JUN
collection PubMed
description This study used a streptozotocin (STZ)-induced rat model of diabetes to investigate whether Ras-related C3 botulinum toxin substrate 1 (Rac1) was involved in the pathogenesis of diabetic retinopathy. The effects of Rac1 inhibition on vascular endothelial (VE)-cadherin and β-catenin expression in high glucose-induced rat retinal endothelial cells (RRECs) were additionally examined. Rac1 activation in the retinas from STZ-induced diabetic rats and in high glucose-induced RRECs was measured by reverse transcription-quantitative polymerase chain reaction analysis, immunohistochemistry and western blot analysis. The expression levels of VE-cadherin and β-catenin were also examined with or without Rac1 inhibition through small interfering (si)RNA transfection. STZ-induced diabetes was associated with an increase in the vascular permeability of the retina. Furthermore, Rac1 activation was increased in the retina of STZ-induced diabetic rats and in high glucose-induced RRECs compared with that in the controls. Immunohistochemistry showed that immunostaining of Rac1 was localized in the outer plexiform, inner nuclear, inner plexiform and ganglion cell layers and in the retinal microvasculature of rats. The expression of β-catenin was increased in the retinas of the diabetic rats at four, eight and 12 weeks after the induction of diabetes compared with that in the controls. Additionally, Rac1 activation was required for the high glucose-induced VE-cadherin expression decrease and for β-catenin expression in high glucose-induced RRECs. Rac1 inhibition by Rac1-siRNA transfection effectively prevented hyperpermeability, β-catenin expression and the VE-cadherin expression decrease in high glucose-induced RRECs. In conclusion, diabetes affects the expression of Rac1 in the retina. Rac1 may be involved in the diabetes-induced damage and/or alterations to the blood-retinal barrier through changes in VE-cadherin and β-catenin expression.
format Online
Article
Text
id pubmed-4247314
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-42473142014-12-01 Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy LI, YANG-JUN ZHANG, JIE HAN, JING DU, ZHAO-JIANG WANG, PING GUO, YONG Exp Ther Med Articles This study used a streptozotocin (STZ)-induced rat model of diabetes to investigate whether Ras-related C3 botulinum toxin substrate 1 (Rac1) was involved in the pathogenesis of diabetic retinopathy. The effects of Rac1 inhibition on vascular endothelial (VE)-cadherin and β-catenin expression in high glucose-induced rat retinal endothelial cells (RRECs) were additionally examined. Rac1 activation in the retinas from STZ-induced diabetic rats and in high glucose-induced RRECs was measured by reverse transcription-quantitative polymerase chain reaction analysis, immunohistochemistry and western blot analysis. The expression levels of VE-cadherin and β-catenin were also examined with or without Rac1 inhibition through small interfering (si)RNA transfection. STZ-induced diabetes was associated with an increase in the vascular permeability of the retina. Furthermore, Rac1 activation was increased in the retina of STZ-induced diabetic rats and in high glucose-induced RRECs compared with that in the controls. Immunohistochemistry showed that immunostaining of Rac1 was localized in the outer plexiform, inner nuclear, inner plexiform and ganglion cell layers and in the retinal microvasculature of rats. The expression of β-catenin was increased in the retinas of the diabetic rats at four, eight and 12 weeks after the induction of diabetes compared with that in the controls. Additionally, Rac1 activation was required for the high glucose-induced VE-cadherin expression decrease and for β-catenin expression in high glucose-induced RRECs. Rac1 inhibition by Rac1-siRNA transfection effectively prevented hyperpermeability, β-catenin expression and the VE-cadherin expression decrease in high glucose-induced RRECs. In conclusion, diabetes affects the expression of Rac1 in the retina. Rac1 may be involved in the diabetes-induced damage and/or alterations to the blood-retinal barrier through changes in VE-cadherin and β-catenin expression. D.A. Spandidos 2015-01 2014-11-19 /pmc/articles/PMC4247314/ /pubmed/25452781 http://dx.doi.org/10.3892/etm.2014.2081 Text en Copyright © 2015, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
LI, YANG-JUN
ZHANG, JIE
HAN, JING
DU, ZHAO-JIANG
WANG, PING
GUO, YONG
Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
title Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
title_full Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
title_fullStr Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
title_full_unstemmed Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
title_short Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
title_sort ras-related c3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247314/
https://www.ncbi.nlm.nih.gov/pubmed/25452781
http://dx.doi.org/10.3892/etm.2014.2081
work_keys_str_mv AT liyangjun rasrelatedc3botulinumtoxinsubstrate1activationisinvolvedinthepathogenesisofdiabeticretinopathy
AT zhangjie rasrelatedc3botulinumtoxinsubstrate1activationisinvolvedinthepathogenesisofdiabeticretinopathy
AT hanjing rasrelatedc3botulinumtoxinsubstrate1activationisinvolvedinthepathogenesisofdiabeticretinopathy
AT duzhaojiang rasrelatedc3botulinumtoxinsubstrate1activationisinvolvedinthepathogenesisofdiabeticretinopathy
AT wangping rasrelatedc3botulinumtoxinsubstrate1activationisinvolvedinthepathogenesisofdiabeticretinopathy
AT guoyong rasrelatedc3botulinumtoxinsubstrate1activationisinvolvedinthepathogenesisofdiabeticretinopathy